(CN106200601) 本​发明​提供​种​智能​家居​燃气​生态​监测​及​控制系统，其​包括​中央​控制系统、监测​系统​和​燃料​处理系统，通过​监测​系统​采集​系统​运行​数据​和​环境​数据，由​中央​控制系统​对数​据​进行​智能化​分析​并​控制​家居​设备​的​运行，燃料​处理系统​先​件​对​气体燃料​进行​预处理，使​气体燃料​带有​催化​载体，再利用​同​极​共振​加载​及其​传递​处理​技术，改变​燃料​电子​云的​排​布​结构，降低​燃料​所需​活化能，提高​分子​间的​有效​碰撞​率，裂解​积​碳，使​燃料​进行​充分​燃烧，同时​利用​增效​载体​使​燃烧​产物​发生​甲烷​化​反应​和​水煤气​反应，形成​个​链式​增​燃​反应​使​单位​燃料​释放​更多​发热量，并​减少​污染物​的​生成，本​发明​具有​智能化、对​气体燃料​充分​处理、节气、污染物​减排​等​优点。

(CN106174658) 本​发明​公开​了​种​畜禽​死​体​无害化​处理机，涉及​畜禽​无害化​处理​技术​领域。本​发明​包括​粉碎​搅拌​装置、螺旋​输送​装置​和​饲料​成型​装置，所​述​粉碎​搅拌​装置​与​螺旋​输送​装置​端​连接，螺旋​输送​装置​的​另​端​与​饲料​成型​装置​连接；在​粉碎​搅拌​装置​与​螺旋​输送​装置​之间​设置​有​添加​料斗，所​述​添加​料斗​对应​设置​在​螺旋​输送​装置​的​输送​进口​处；本​发明​的​无害化​处理系统，成本​较低，且​无害化​处理​后的​残渣，可以​用来​制作​可再​次​利用​的​产品，提高​资源​利用率。

(CN106169348) 本​发明​公开​了​种​铁​硅​铝合金​的​微波​高温​合成​方法，该​方法​包括：配料、粉碎​研磨、加压​处理、高温​合成。采用​本​方法​合成​铁​硅​铝合金，能够​有效​的​降低​能耗​和​加工​时间，充分发挥​了​微波​合成​的​高效​特点，能够​实现​大规模​生产，应用​前景​极佳。

(CN106111508) 本​发明​公开​了​种​变速器​壳体​的​表面​涂覆​方法，对​变速器​壳体​进行​清洗​及​喷​砂​预处理；将​预处理​后的​变速器​壳体​浸入​电解液​中，施加​脉冲​电流，在​表面上​涂有​金属​氧化物​形成​陶瓷​涂层；然后​喷涂​石墨​涂层，再​浸入​环氧树脂​溶液​中，烘干；将​烘干​后的​变速器​壳体​加热​到​240～280℃，维持​3​~​5h；固化​后​进行​冷却，获得​表面​涂覆​的​变速器​壳体。可​涂在​所有​基底​金属​合金​上，抗​腐蚀​性能​好，可与​基体​形成​个​整体，具有​不易​破碎​或​脱落，显著​提高​部件​表面的​耐磨性、硬度​和​寿命。

(JP2017025069) PROBLEM TO BE SOLVED: To provide a treating means of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP), used for: promoting bone growth; promoting hair growth; preventing cancer metastasis to bone; promoting immune reconstitution with a bone marrow stem cell transplant; promoting mobilization of bone marrow stem cells for collection for autologous stem cell; treating renal osteodystrophy; and the like.SOLUTION: This invention relates to bacterial collagen-binding fusion proteins containing active agonist or antagonist fragments of PTH and PTHrP coupled to a collagen-binding domain. This invention further relates to a method for: promoting bone growth; promoting hair growth; preventing cancer metastasis to bone; promoting immune reconstitution with a bone marrow stem cell transplant; promoting mobilization of bone marrow stem cells for collection for autologous stem cell; and treating renal osteodystrophy, the method comprising administering to a mammal the fusion proteins. This invention also relates to pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist.SELECTED DRAWING: Figure 3

(IN201647029678) The invention relates to a method for coating metallic surfaces of substrates with surfaces of aqueous compositions, hereinafter also referred to as coating compositions, in the form of a dispersion and/or a suspension containing at least one stabilized binder and a gelling agent and with the cations dissolved out of the metallic surface in a pretreatment stage and/or during the contacting, and the invention relates to such a coating based on an ionogenic gel, in which the coating is formed by: I. Providing a substrate with a cleaned metallic surface, II. Contacting and coating the metallic surface with a first aqueous composition in the form of a dispersion or suspension, III. Optionally rinsing the organic coating, IV. Optionally drying the organic coating and V. Coating with at least one additional coating composition before drying and cross linking all applied layers, wherein the stabilized binder must fulfill the following conditions: a) an aqueous mixture of deionized water, 0.2% to 2% by weight of the gelling agent and 5% to 20% by weight of the stabilized binder b) is adjusted to a pH of 1 to 7; c) a cleaned substrate is immersed in the mixture according to b) for at least 1 minute at room temperature and d) a check is performed on whether an organic coating of at least 1 pm has been deposited, wherein e) an additional test without a gelling agent is performed by preparing a mixture of deionized water and 5% to 20% by weight of the dispersion to be tested; f) the mixture prepared under e) is also adjusted to a pH of 1 to 7 and g) the test described under c) and d) is repeated.

(JP2017087712) PROBLEM TO BE SOLVED: To provide a hiding printed matter capable of easily confirming hiding contents, and capable of repeated use since hiding contents are reversibly disappeared, and a method for printing a hiding printed matter.SOLUTION: Provided is a hiding printed matter having a hydrophilic base material part formed on a hydrophobic base material.SELECTED DRAWING: Figure 1

(CN106276878) 本​发明​提供​种​电​沉积​制备​石墨​烯​泡沫​的​方法，包括​以下​几个​步骤：步骤（1）将​氧化​石墨​加入​到​球磨机​中​球​磨，然后​将​球​磨​后的​氧化​石墨​加入​到​水中​超声​分散，形成​悬浮液；步骤（2）将​金属​盐​硫酸铝​或者​硫酸镁​或者​氯化铝​加入​到​上述​悬浮液​中​制备​成​电解液，然后​将​石墨​电极​和​泡沫​镍​电极​插入​到​电解液​中，分别​连接​恒压​电源​的​正负​极，接通​电源​进行​电​沉积​反应；步骤（3）取下​泡沫​镍​电极，蒸​干​溶剂，再放​入​氢​氮​混合​气​保护​的​马弗​炉​内​反应，反应​完全​后​自然​冷却；步骤（4）将上​述​的​产物​浸渍​于​盐酸​中，反应，反应​完全​后​得到​泡沫​石墨​烯。本​发明​的​方法​设备​要求​简单，操作​容易。

(JP2016188251) PROBLEM TO BE SOLVED: To prove the physiological activities of 3,6-anhydro-L-galactose, thereby enabling industrial use thereof.SOLUTION: The present invention relates to a cosmetic composition for skin moisturizing comprising 3,6-anhydro-L-galactose.SELECTED DRAWING: Figure 1

(US20170189489) A method of causing cardiomyocyte growth and/or differentiation, the method comprising exposing a cardiomyocyte to neuregulin (NRG) thereby activating the MAP kinase pathway in the cardiomyocyte and causing growth and/or differentiation of the cardiomyocyte. Use of neuregulin, neuregulin polypeptide, neuregulin derivatives, or compounds which mimic the activities of neuregulins in the treatment or management of heart disease and heart failure in a mammal.